# Arbor Realty Trust Inc: financial statements, quarterly

ABR · NYSE · CIK 1253986 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abr.md) · [Financials](/companies/abr/financials.md) · [Filings](/companies/abr/filings.md) · [Insiders](/companies/abr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/abr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [12.7 d](/filings/0001253986-26-000019.md) | [13.9](/filings/0001628280-25-021683.md) | [12.8](/filings/0001253986-25-000014.md) | [13.1](/filings/0001253986-25-000022.md) | [15.0 d](/filings/0001253986-26-000019.md) | [16.3](/filings/0001253986-26-000036.md) | [14.9](/filings/0001253986-26-000048.md) | [13.7](/filings/0001253986-26-000063.md) | [14.9 d](/filings/0001253986-26-000019.md) | [17.0](/filings/0001253986-26-000036.md) | [15.9](/filings/0001253986-26-000048.md) | [15.4](/filings/0001253986-26-000063.md) |
| Interest expense | $m | [227 d](/filings/0001628280-24-005456.md) | [218](/filings/0001628280-24-020155.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.9 d](/filings/0001253986-26-000019.md) | [3.6](/filings/0001628280-25-021683.md) | [3.9](/filings/0001253986-25-000014.md) | [5.2](/filings/0001253986-25-000022.md) | [0.8 d](/filings/0001253986-26-000019.md) | [3.6](/filings/0001253986-26-000036.md) | [3.4](/filings/0001253986-26-000048.md) | [7.6](/filings/0001253986-26-000063.md) | [4.2 d](/filings/0001253986-26-000019.md) | [2.1](/filings/0001253986-26-000036.md) | [3.2](/filings/0001253986-26-000048.md) | [(1.2)](/filings/0001253986-26-000063.md) |
| Net income | $m | [110 d](/filings/0001253986-26-000019.md) | [73.2](/filings/0001628280-25-021683.md) | [61.8](/filings/0001253986-25-000014.md) | [73.5](/filings/0001253986-25-000022.md) | [75.3 d](/filings/0001253986-26-000019.md) | [43.4](/filings/0001253986-26-000036.md) | [36.3](/filings/0001253986-26-000048.md) | [52.0](/filings/0001253986-26-000063.md) | [26.1 d](/filings/0001253986-26-000019.md) | [11.0](/filings/0001253986-26-000036.md) | [(30.2)](/filings/0001253986-26-000048.md) | [(82.4)](/filings/0001253986-26-000063.md) |
| Diluted EPS | $ per share | not reported | [0.31](/filings/0001628280-25-021683.md) | [0.25](/filings/0001253986-25-000014.md) | [0.31](/filings/0001253986-25-000022.md) | not reported | [0.16](/filings/0001253986-26-000036.md) | [0.12](/filings/0001253986-26-000048.md) | [0.20](/filings/0001253986-26-000063.md) | not reported | [0.00](/filings/0001253986-26-000036.md) | [(0.20)](/filings/0001253986-26-000048.md) | [(0.51)](/filings/0001253986-26-000063.md) |
| Basic EPS | $ per share | not reported | [0.31](/filings/0001628280-25-021683.md) | [0.25](/filings/0001253986-25-000014.md) | [0.31](/filings/0001253986-25-000022.md) | not reported | [0.16](/filings/0001253986-26-000036.md) | [0.12](/filings/0001253986-26-000048.md) | [0.20](/filings/0001253986-26-000063.md) | not reported | [0.00](/filings/0001253986-26-000036.md) | [(0.20)](/filings/0001253986-26-000048.md) | [(0.51)](/filings/0001253986-26-000063.md) |

- Revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0001253986-26-000019.md) | [0.9](/filings/0001628280-25-021683.md) | [0.7](/filings/0001253986-25-000014.md) | [0.7](/filings/0001253986-25-000022.md) | [0.5](/filings/0001253986-26-000063.md) | [0.3](/filings/0001253986-26-000036.md) | [0.3](/filings/0001253986-26-000048.md) | [0.4](/filings/0001253986-26-000063.md) | [0.5](/filings/0001253986-26-000063.md) | [0.4](/filings/0001253986-26-000036.md) | [0.3](/filings/0001253986-26-000048.md) | [0.4](/filings/0001253986-26-000063.md) |
| Total assets | $bn | [15.7](/filings/0001628280-25-007183.md) | [15.1](/filings/0001628280-24-020155.md) | [14.2](/filings/0001628280-24-034905.md) | [13.9](/filings/0001628280-24-044661.md) | [13.5](/filings/0001253986-26-000019.md) | [13.4](/filings/0001628280-25-021683.md) | [13.6](/filings/0001253986-25-000014.md) | [13.9](/filings/0001253986-25-000022.md) | [14.5](/filings/0001253986-26-000063.md) | [14.7](/filings/0001253986-26-000036.md) | [14.4](/filings/0001253986-26-000048.md) | [14.2](/filings/0001253986-26-000063.md) |
| Total liabilities | $bn | [12.5](/filings/0001628280-25-007183.md) | [11.9](/filings/0001628280-24-020155.md) | [11.0](/filings/0001628280-24-034905.md) | [10.7](/filings/0001628280-24-044661.md) | [10.3](/filings/0001253986-26-000019.md) | [10.2](/filings/0001628280-25-021683.md) | [10.5](/filings/0001253986-25-000014.md) | [10.8](/filings/0001253986-25-000022.md) | [11.4](/filings/0001253986-26-000063.md) | [11.7](/filings/0001253986-26-000036.md) | [11.5](/filings/0001253986-26-000048.md) | [11.6](/filings/0001253986-26-000063.md) |
| Long-term debt | $bn | [12.0](/filings/0001628280-24-005456.md) | [11.4](/filings/0001628280-24-020155.md) | [10.6](/filings/0001628280-24-034905.md) | [10.3](/filings/0001628280-24-044661.md) | [10.0](/filings/0001628280-25-007183.md) | [9.9](/filings/0001628280-25-021683.md) | [10.1](/filings/0001253986-25-000014.md) | [10.4](/filings/0001253986-25-000022.md) | [11.1](/filings/0001253986-26-000019.md) | [11.4](/filings/0001253986-26-000036.md) | [11.1](/filings/0001253986-26-000048.md) | [11.2](/filings/0001253986-26-000063.md) |
| Shareholders' equity | $bn | [3.1](/filings/0001628280-25-007183.md) | [3.1](/filings/0001628280-24-020155.md) | [3.1](/filings/0001628280-24-034905.md) | [3.0](/filings/0001628280-24-044661.md) | [3.0](/filings/0001253986-26-000019.md) | [3.0](/filings/0001628280-25-021683.md) | [3.0](/filings/0001253986-25-000014.md) | [3.0](/filings/0001253986-25-000022.md) | [3.0](/filings/0001253986-26-000063.md) | [2.9](/filings/0001253986-26-000036.md) | [2.8](/filings/0001253986-26-000048.md) | [2.5](/filings/0001253986-26-000063.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [77.2 d](/filings/0001253986-26-000019.md) | [260](/filings/0001628280-25-021683.md) | [69.9 d](/filings/0001253986-25-000014.md) | [85.0 d](/filings/0001253986-25-000022.md) | [46.7 d](/filings/0001253986-26-000019.md) | [151](/filings/0001253986-26-000036.md) | [60.0 d](/filings/0001253986-26-000048.md) | [179 d](/filings/0001253986-26-000063.md) | [(16.9) d](/filings/0001253986-26-000019.md) | [(8.3)](/filings/0001253986-26-000036.md) | [158 d](/filings/0001253986-26-000048.md) | [202 d](/filings/0001253986-26-000063.md) |
| Dividends paid | $m | [98.6 d](/filings/0001253986-26-000019.md) | [98.7](/filings/0001628280-25-021683.md) | [98.6 d](/filings/0001253986-25-000014.md) | [98.6 d](/filings/0001253986-25-000022.md) | [99.0 d](/filings/0001253986-26-000019.md) | [99.4](/filings/0001253986-26-000036.md) | [73.1 d](/filings/0001253986-26-000048.md) | [73.4 d](/filings/0001253986-26-000063.md) | [74.1 d](/filings/0001253986-26-000019.md) | [73.3](/filings/0001253986-26-000036.md) | [45.5 d](/filings/0001253986-26-000048.md) | [44.9 d](/filings/0001253986-26-000063.md) |
| Share repurchases | $m | [(0.0) d](/filings/0001253986-26-000019.md) | [0.0](/filings/0001628280-24-020155.md) | [11.4 d](/filings/0001253986-25-000014.md) | [0.0 d](/filings/0001253986-25-000022.md) | [0.0 d](/filings/0001253986-26-000019.md) | [0.0](/filings/0001253986-26-000036.md) | [0.0 d](/filings/0001253986-26-000048.md) | [0.0 d](/filings/0001253986-26-000063.md) | [2.0 d](/filings/0001253986-26-000019.md) | [30.7](/filings/0001253986-26-000036.md) | [20.9 d](/filings/0001253986-26-000048.md) | [115 d](/filings/0001253986-26-000063.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [215](/filings/0001628280-24-020155.md) | [216](/filings/0001628280-24-034905.md) | [221](/filings/0001628280-24-044661.md) | [223](/filings/0001628280-25-021683.md) | [205](/filings/0001253986-25-000014.md) | [205](/filings/0001253986-25-000022.md) | [207](/filings/0001253986-26-000036.md) | [209](/filings/0001253986-26-000048.md) | [211](/filings/0001253986-26-000063.md) | [212](/filings/0001253986-26-000036.md) | [191](/filings/0001253986-26-000048.md) | [169](/filings/0001253986-26-000063.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 184,176,631 at 2026-10-23, from the cover of the [10-Q filed 2026-10-30](/filings/0001253986-26-000063.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 03:25 ET. No prices; not investment advice.